Edwards Lifesciences just saw its modeled fair value edge from US$96.93 to US$96.96, a tiny move that still reflects fresh thinking about where the shares might reasonably trade. That small adjustment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results